Chien-hsiu Li
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
c-Myc transactivates CFL1 to induce senescence-like phenotype and potentiate the bystander effects for the migration and proliferation in lung cancer cells.
Journal: Cell death discovery
Published: November 28, 2025
Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer.
Journal: Cancer letters
Published: May 17, 2024
Implications of the KHDC4-TRAF2 axis in the context of prostate cancer prognosis.
Journal: Aging
Published: March 25, 2024
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Journal: Cell death & disease
Published: January 29, 2024
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression.
Journal: Cell communication and signaling : CCS
Published: December 07, 2023
RAB31 drives extracellular vesicle fusion and cancer-associated fibroblast formation leading to oxaliplatin resistance in colorectal cancer.
Journal: Journal of extracellular biology
Published: September 21, 2023
WNT1-inducible signaling pathway protein 1 activation through C-X-C motif chemokine ligand 5/C-X-C chemokine receptor type 2/leukemia inhibitory factor/leukemia inhibitory factor receptor signaling promotes immunosuppression and neuroendocrine differentiation in prostate cancer.
Journal: iScience
Published: August 29, 2023
Comprehensive Neurotoxicity of Lead Halide Perovskite Nanocrystals in Nematode Caenorhabditis elegans.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: July 18, 2023
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Journal: Cell death & disease
Published: January 04, 2023
Gold Nanoparticles as a Biosensor for Cancer Biomarker Determination.
Journal: Molecules (Basel, Switzerland)
Published: November 15, 2022
Last Updated: 09/26/2026